Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Hikma Pharmaceutical (OP: HKMPF )

30.65 USD -0.66 (-2.10%)
Official Closing Price Updated: 10:24 AM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Hikma Pharmaceutical

< Previous 1 2 Next >
Markets Up As US Clears Path For Moderna Vaccine Approval
European markets have opened positively this morning with Germany’s Dax leading the way up 1.6% as optimism creeps in surrounding vaccination and the prospect of US fiscal stimulus ahead of Central... 
Tags Cryptocurrencies Stocks / Equities Technology
From Blogs - TalkMarkets
Hikma receives FDA approval for generic of Amarin's Vascepa
Hikma Pharmaceuticals announced overnight that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA has received approval from the Food and Drug Administration for its Icosapent Ethyl Capsules,... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Is Amarin Stock a Buy?
Record revenues, international growth, and a potential legal strategy may provide upside. 
Tags RDY HKMPF ACAD
From Motley Fool
Are Amarin's Blockbuster Dreams Over?
A ruling that invalidated Amarin’s patents means generic competition for its cardiovascular drug may be right around the corner. 
Tags Market News AMRN PFE
From Motley Fool
Why Did Amarin's Stock Fall Off a Cliff?
Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge. 
Tags HKMPY AMRN Market News
From Motley Fool
1 Cheap Biotech Stock to Buy
The market is in sell-off mode, but that doesn't mean you should stop buying stocks. 
Tags HKMPF JAZZ Market News
From Motley Fool
Could Amarin Be a Millionaire Maker Stock?
Vascepa has a good chance of being a blockbuster, but an upcoming patent decision will have the final word. 
Tags RDY HKMPF AZN
From Motley Fool
Ternium SA Is A Strong Buy
Ternium, Orchid Island, and Mazda are "strong buy" stocks. 
Tags Stocks / Equities
From Blogs - TalkMarkets
News Beyond GSK R&D
Gold is flat on its back again, with no rise since the start of the year at $1115/oz. Oil meanwhile has gushed in price to $48.18/bbl, up nearly 4.5% just in time for a colder weather. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Step 9 - Financial Review
Microsoft is skipping from Windows 8 to Windows 10, and many people wonder what happened to number 9. I think I know; they replaced Windows 9 with Step 9, which requires them to make amends. 
Tags Financial Consumer Goods Transportation
From Blogs - TalkMarkets
UPDATE 1-Hikma profit jumps on strong injectible drugs sales
March 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by a stronger-than-expected performance at its high-margin injectible drugs business. 
Tags companyNews
From Reuters: Company News
Hikma profit jumps on strong injectible drug sales
March 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by strong demand for its high-margin injectible drugs, particularly in the United States. 
Tags companyNews
From Reuters: Company News
BRIEF-Hikma Pharma says preparing to distribute Colchicine
* Prepare to distribute its colchicine, which it will market under brand name mitigare 
Tags companyNews
From Reuters: Company News
PRESS DIGEST- Financial Times - Dec 22
Dec 22 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
UPDATE 1-Hikma raises full-year revenue forecast
Nov 6 (Reuters) - Drugmaker Hikma Pharmaceuticals Plc raised its full-year revenue growth target to 7 percent, citing strong demand for its high-margin injectible drugs, particularly in the United... 
Tags companyNews
From Reuters: Company News
BRIEF-Hikma says U.S. court grants temporary restraining order on co's Colchicine capsules
* Notes that us district court for district of delaware has granted takeda pharmaceuticals u.s. a motion for a temporary restraining order in relation to further distribution of hikma's fda-approved... 
Tags companyNews
From Reuters: Company News
BRIEF-Hikma Pharma to buy Ben Venue's generic injectables factory
* Agreed with Ben Venue Laboratories, Inc. , part of Boehringer Ingelheim Group of companies, to acquire their generic injectables manufacturing site in Bedford, Ohio 
Tags companyNews
From Reuters: Company News
Hikma buys Boehringer injectable drugs business for up to $300 mln
LONDON, May 28 (Reuters) - Hikma Pharmaceuticals said on Wednesday it had agreed to acquire assets from the U.S. generic injectable drugs business of Germany's Boehringer Ingelheim for up to $300... 
Tags companyNews
From Reuters: Company News
Hikma Pharma says US FDA lifts warning on Eatontown facility
April 2 (Reuters) - Hikma Pharmaceuticals Plc said on Wednesday that the U.S. Food and Drug Administration had lifted the warning on its Eatontown facility in New Jersey where it makes oral products... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Hikma full-year profit doubles on strong doxycycline sales
* Expects injectibles revenue to rise 20 percent this year 
Tags companyNews
From Reuters: Company News
Hikma full-year profit doubles on strong doxycycline sales
March 12 (Reuters) - Hikma Pharmaceuticals Plc's full-year profit more than doubled helped by strong demand and higher prices for the antibiotic doxycycline that is used in the treatment bacterial... 
Tags companyNews
From Reuters: Company News
PRESS DIGEST- British Business - Feb 12
Feb 12 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 11 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 10 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 10 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 07 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 07 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 07 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 07 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
DIARY - WEU EARNINGS Events - Part 3
*** TO SEE THE DATES BEFORE FEB 26 - PLEASE CLICK ON TO SEE THE DATES BEFORE FEB 07 - PLEASE CLICK ON ------- ---- ---- ------------------- --------- --------- DATE CO GMT COMPANY NAME EVENT RIC... 
Tags companyNews
From Reuters: Company News
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.